文献速递其他结缔组织病

弥漫性系统性硬化症自体干细胞移植后心脏功能的纵向变化

Longitudinal Changes in Cardiac Function Following Autologous Stem Cell Transplantation in Diffuse Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2026-09-15

在Leiden系统性硬化症队列中,43例接受自体干细胞移植(ASCT)的弥漫性SSc患者与43例对照按性别、年龄和病程1:1匹配。ASCT与左室射血分数(LVEF)和整体纵向应变(GLS)的显著年度改善相关,而对照组呈进行性下降;LV GLS的时间依赖性变化与全因死亡率独立相关。

要点

  • ASCT与弥漫性SSc患者LVEF和GLS的显著年度改善相关,舒张功能保持稳定。
  • LV GLS的时间依赖性变化与全因死亡率独立相关(aHR 0.73/%,95%CI 0.61-0.86,P=0.0002)。
  • 研究支持ASCT的心脏安全性,并提示需用高级超声心动图进行纵向监测。

核心结论

  • 在弥漫性SSc患者中,ASCT与心脏收缩功能随时间显著改善相关,且对舒张功能无不良影响。

研究设计与样本

  • 来自Leiden系统性硬化症队列,43例接受ASCT的弥漫性SSc患者与43例对照按性别、年龄和病程1:1匹配,排除有明显心脏或肺部受累者,每年进行系列超声心动图检查。

主要发现

  • 基线时ASCT组LVEF为52.5%±9.1% vs 对照组56.1%±6.3%(P=0.044),LV GLS为18.0%±2.6% vs 19.5%±2.5%(P=0.014)。
  • 随访期间ASCT与LVEF改善相关(校正β=1.59%/年,P<0.001),与GLS改善相关(校正β=0.71%/年,P<0.001),而对照组呈进行性下降。
  • 两组舒张参数随时间保持稳定。
  • LV GLS的时间依赖性变化与全因死亡率独立相关(校正风险比0.73/%,95%CI 0.61-0.86,P=0.0002),LVEF无此关联。

关键数值与推荐

  • LV GLS时间依赖性变化与全因死亡的校正风险比为0.73/%(95%CI 0.61-0.86,P=0.0002)。

临床怎么用

  • ASCT后应使用包括GLS在内的高级超声心动图对弥漫性SSc患者进行纵向心脏监测。
  • LV GLS的纵向变化可能有助于识别ASCT后全因死亡风险较高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cardiovascular involvement is frequent in patients with systemic sclerosis (SSc). Autologous stem cell transplantation (ASCT) has emerged as a disease-modifying therapy for diffuse SSc, but its long-term impact on cardiac function remains unclear. We aim to examine the changes in left ventricular (LV) function after ASCT and their potential prognostic significance. METHODS: From the Leiden Systemic Sclerosis cohort, 43 patients with diffuse SSc who underwent ASCT were matched 1:1 with controls with SSc based on sex, age, and disease duration. Patients with overt cardiac or pulmonary involvement were excluded. Serial echocardiography was performed annually, including LV ejection fraction (LVEF), global longitudinal strain (GLS), and diastolic parameters. RESULTS: Among the included patients, mean age was 44.1 ± 10.5 years; 52.3% were female. At baseline, patients with ASCT showed mildly reduced LVEF (52.5% ± 9.1% vs 56.1% ± 6.3%, P = 0.044) and LV GLS (18.0% ± 2.6% vs 19.5% ± 2.5%, P = 0.014) compared to controls. During follow-up, ASCT was associated with significant improvement in LVEF (adjusted β = 1.59%/y, P < 0.001) and GLS (adjusted β = 0.71%/y, P < 0.001), whereas controls showed progressive decline. Diastolic parameters remained stable over time in both groups. Time-dependent changes in LV GLS, but not LVEF, were independently associated with all-cause mortality (adjusted hazard ratio 0.73 per %, 95% confidence interval 0.61-0.86, P = 0.0002). CONCLUSION: In patients with diffuse SSc, ASCT is associated with significant improvements in cardiac systolic function over time without adverse effects on diastolic function. These findings support the cardiac safety of ASCT, suggest potential cardiovascular benefit beyond systemic disease control, and highlight the importance of longitudinal monitoring with advanced echocardiography in SSc.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. He J, Butcher SC, Wang X, et al. Longitudinal Changes in Cardiac Function Following Autologous Stem Cell Transplantation in Diffuse Systemic Sclerosis. Arthritis Rheumatol. 2026. PMID: 42742097. doi:10.1002/art.70338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。